Evidence-Based Medicine Guidelines
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Peroxisome Proliferator-activated Receptor Gamma Agonists for Preventing Recurrent Stroke and Other Vascular Events in Patients With Stroke or Transient Ischaemic Attack." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458473/all/Peroxisome_proliferator_activated_receptor_gamma_agonists_for_preventing_recurrent_stroke_and_other_vascular_events_in_patients_with_stroke_or_transient_ischaemic_attack.
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/458473/all/Peroxisome_proliferator_activated_receptor_gamma_agonists_for_preventing_recurrent_stroke_and_other_vascular_events_in_patients_with_stroke_or_transient_ischaemic_attack. Accessed March 25, 2023.
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458473/all/Peroxisome_proliferator_activated_receptor_gamma_agonists_for_preventing_recurrent_stroke_and_other_vascular_events_in_patients_with_stroke_or_transient_ischaemic_attack
Peroxisome Proliferator-activated Receptor Gamma Agonists for Preventing Recurrent Stroke and Other Vascular Events in Patients With Stroke or Transient Ischaemic Attack [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458473/all/Peroxisome_proliferator_activated_receptor_gamma_agonists_for_preventing_recurrent_stroke_and_other_vascular_events_in_patients_with_stroke_or_transient_ischaemic_attack.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack
ID - 458473
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458473/all/Peroxisome_proliferator_activated_receptor_gamma_agonists_for_preventing_recurrent_stroke_and_other_vascular_events_in_patients_with_stroke_or_transient_ischaemic_attack
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
